BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21252292)

  • 41. Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2
    Fang Y; Yang C; Zhang L; Wei L; Lin J; Zhao J; Peng J
    Biomed Res Int; 2019; 2019():5953619. PubMed ID: 31662984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs.
    Chen W; Qiu J; Shen YM
    Drug Discov Ther; 2012 Oct; 6(5):230-7. PubMed ID: 23229142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy.
    Ma Y; North BJ; Shu J
    Mol Biol Rep; 2021 Sep; 48(9):6589-6601. PubMed ID: 34476738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78.
    Kotecha M; Kluza J; Wells G; O'Hare CC; Forni C; Mantovani R; Howard PW; Morris P; Thurston DE; Hartley JA; Hochhauser D
    Mol Cancer Ther; 2008 May; 7(5):1319-28. PubMed ID: 18483319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide.
    Tammaro M; Barr P; Ricci B; Yan H
    PLoS One; 2013; 8(11):e79202. PubMed ID: 24244448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas.
    Shibao K; Takano H; Nakayama Y; Okazaki K; Nagata N; Izumi H; Uchiumi T; Kuwano M; Kohno K; Itoh H
    Int J Cancer; 1999 Dec; 83(6):732-7. PubMed ID: 10597187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
    Asano T; Kleinerman ES; Zwelling LA; Zhou Z; Fukunaga Y
    Acta Oncol; 2005; 44(3):240-7. PubMed ID: 16076696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel selection and genetic characterisation of an etoposide-resistant human leukaemic CCRF-CEM cell line.
    Patel S; Fisher LM
    Br J Cancer; 1993 Mar; 67(3):456-63. PubMed ID: 8382508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning.
    Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G
    Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
    Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
    Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance.
    Taki T; Ohnishi T; Arita N; Hiraga S; Hayakawa T
    J Neurooncol; 1998 Jan; 36(1):41-53. PubMed ID: 9525824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
    Menendez JA; Vellon L; Lupu R
    Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha.
    de Lucio B; Manuel V; Barrera-Rodríguez R
    Cancer Sci; 2005 Nov; 96(11):774-83. PubMed ID: 16271071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26.
    Catapano CV; Carbone GM; Pisani F; Qiu J; Fernandes DJ
    Biochemistry; 1997 May; 36(19):5739-48. PubMed ID: 9153414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
    Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
    Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.
    Danks MK; Schmidt CA; Cirtain MC; Suttle DP; Beck WT
    Biochemistry; 1988 Nov; 27(24):8861-9. PubMed ID: 2853972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
    Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
    Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-yield production and characterization of biologically active GST-tagged human topoisomerase IIα protein in insect cells for the development of a high-throughput assay.
    Singh PK; Chan PF; Hibbs MJ; Vazquez MJ; Segura DC; Thomas DA; Theobald AJ; Gallagher KT; Hassan NJ
    Protein Expr Purif; 2011 Apr; 76(2):165-72. PubMed ID: 20709174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
    Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of topoisomerase IIA (Top2α) induces telomeric DNA damage and T cell dysfunction during chronic viral infection.
    Dang X; Ogbu SC; Zhao J; Nguyen LNT; Cao D; Nguyen LN; Khanal S; Schank M; Thakuri BKC; Wu XY; Morrison ZD; Zhang J; Li Z; El Gazzar M; Ning S; Wang L; Wang Z; Moorman JP; Yao ZQ
    Cell Death Dis; 2020 Mar; 11(3):196. PubMed ID: 32193368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.